标题：Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation
摘要：Correction to:
Scientific Reports 10.1038/s41598-021-81803-6, published online 26 January 2021
The original version of this Article contained an error in Table 2, where in columns “Total cohort (n = 1212)” and “Fasting plasma glucose ≥ 100 mg/dL (n = 423)”, the n values for ‘Normal fructosamine’ and ‘High fructosamine’ were accidently switched. The correct and incorrect heading rows appear below.
Incorrect:
Complications
Total cohort (n = 1212)
Fasting plasma glucose ≥ 100 mg/dL (n = 423)
Normal fructosamine (n = 54)
High fructosamine (n = 1158)
p value
Normal fructosamine (n = 32)
High fructosamine (n = 391)
p value
Correct:
Complications
Total cohort (n = 1212)
Fasting plasma glucose ≥ 100 mg/dL (n = 423)
Normal fructosamine (n = 1158)
High fructosamine (n = 54)
p value
Normal fructosamine (n = 391)
High fructosamine (n = 32)
p value
The original Article has been corrected.
